The Canadian cannabis market shifted into a new gear with the launch of Cannabis 2.0 products in late 2019. Cannabis 2.0 products include edibles, extracts, and vaporizers. This segment of the cannabis market carries with it much higher profit margins than dried flower products do. Companies and investors are thus cautiously optimistic about a second green rush occurring. These three…
Read More
The cannabis sector has experienced a bumpy ride over the past year. Investors who were late to the party and invested money in 2019 are likely nursing significant losses. However, right now could be an opportune time to invest in cannabis stocks, given the negative sentiment in the sector. Let’s take a look at three top Canadian names in this…
Read More
As the Canadian cannabis space has begun to enter a new phase, it is interesting to look back at how we got here. An initial frantic arms race to accumulate as much production capacity as possible eventually gave way to the reality that demand would be a lot slower to migrate to the legal market than market participants had hoped.…
Read More
Growth investors may be enticed to consider various cannabis stocks today on stock price alone. One must think that if a group of stocks loses the vast majority of their value in a short period, value is beneath the surface. I’m going to explain why I believe this is a dangerous perspective. Even the best cannabis stocks are in trouble…
Read More
Everyone knows that diversification is key to investing, as it protects investors from too much exposure into one specific sector. Having cannabis stocks in your portfolio may be a great idea if you are looking for a well-rounded portfolio. In Canada, marijuana has been legalized for medical use since 2001 and recreational use since 2018. This has allowed the industry…
Read More
Investors that have lost their shirts with various Canadian cannabis stocks over the past year can attest the pain of a bubble and stock prices. Valuations are now at levels that, by some metrics, are at all-time highs. Therefore, investors ought to be more cautious with making large investments in any company right now. In this article, I’m going to…
Read More
Industries across the board continue to suffer thanks to the COVID-19 pandemic. It seems no industry immune to the financial devastation it can cause, including the cannabis industry. Despite the increase in demand and sales of cannabis while people stay home, that hasn’t fixed the problem cannabis suppliers like Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) continue to have: a means of supplying that…
Read More
This recent market turmoil has resulted in what I can only describe as a tectonic shift in the Canadian cannabis sector. Investors have moved from a growth-at-any-cost, risk-seeking base of retail investors to a much more conservative, long-term group of investors. Stock prices tell this story. In this article, I’m going to discuss why, despite more downside likely on the…
Read More
Cannabis investors punished Canopy Growth (TSX:WEED)(NYSE:CGC) after a worse-than-expected earnings report revealing deep cracks in the industry. Canopy plunged as a result. For once, though, the drop looks less like a value opportunity than a wake-up call. But what’s the outlook for this cannabis stock, and why are investors so divided on its outlook? Let’s take a look. Is Canopy…
Read More
You may have seen the recent news about Constellation (NYSE:STZ) exercising warrants to acquire additional shares in Canopy (TSX:WEED)(NYSE:CGC). This announcement was easy to overlook, partly because of its timing (the announcement came out after markets closed on a Friday), partly because Constellation is already Canopy’s largest shareholder, and mostly because of everything else happening in the world right now.…
Read More